3506854
Last Update Posted: 2019-05-22
Recruiting has ended
All Genders accepted | 18 Years + |
16 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients
This is a Phase 1, Multicenter, Open-Label, Parallel Group Adaptive Pharmacokinetic Single Dose Study of ISIS 681257 Subcutaneous Injections in Male And Female Subjects with Normal and Impaired Renal Function
Eligibility
Relevant conditions:
Renal Impairment
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov